术前使用加巴喷丁类药物与因严重外周动脉疾病行下肢旁路手术患者住院时间延长相关
本研究纳入2000至2020年在Penn State Health Milton S. Hershey Medical Center行下肢旁路手术的359例患者,按术前是否使用加巴喷丁类药物(GBP)分为两组,比较术后结局。结果显示GBP组术后住院时间更长(9.3±11.1天 vs 无GBP组6.4±5.0天,P=0.008),多变量分析中GBP组住院时间超过6天中位数的比值比升高(调整OR 1.92 [1.16, 3.18],P=0.01)。
要点
- 术前使用GBP与下肢旁路术后住院时间延长相关(9.3±11.1 vs 6.4±5.0天,P=0.008)。
- GBP组患者更年轻、更常因慢性肢体威胁性缺血手术、更常合并胰岛素依赖型糖尿病。
核心结论
- 术前使用加巴喷丁类药物与因严重外周动脉疾病行下肢旁路手术患者术后住院时间延长存在显著关联。
研究设计与样本
- 回顾性分析2000至2020年在Penn State Health Milton S. Hershey Medical Center行下肢旁路手术的359例患者,按术前是否使用GBP分为GBP组125例和无GBP组234例。
主要发现
- GBP组平均年龄61.6±10.2岁,无GBP组64.6±12.2岁,GBP组更年轻(P=0.014)。
- GBP组更常因慢性肢体威胁性缺血行下肢旁路手术(P=0.039),更常合并胰岛素依赖型糖尿病(P<0.001)。
- GBP组术后住院时间更长(9.3±11.1天 vs 无GBP组6.4±5.0天,P=0.008)。
关键数值与推荐
- 所有分析以P<0.05为显著;主要结局为30天死亡率和住院时间,次要结局包括再入院、非计划重返手术室、截肢、心肌梗死、脑血管意外、肺炎、肺栓塞、尿路感染、伤口并发症、急性充血性心力衰竭加重和非家庭出院。
临床怎么用
- 原文未据此给出推荐.
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to assess the association of preoperative gabapentinoids (GBP) use with the postoperative length of stay for patients undergoing peripheral artery lower extremity bypass (LEB) surgery for lifestyle-limiting claudication and chronic limb-threatening ischemia at a tertiary care hospital. METHODS: Patients undergoing LEB surgery during the period between 2000 and 2020 at Penn State Health Milton S. Hershey Medical Center were stratified into 2 groups based on the preoperative use of prescribed GBPs (GBPs versus no GBPs). Patients' preoperative characteristics, comorbidities and medications were assessed, and the outcomes of interest were analyzed in univariate analysis, stratified analysis, and by multivariable regression models. Primary outcomes were 30-day mortality and length of stay. The secondary outcomes included readmissions, unplanned return to the operating room, amputation, myocardial infarction, cerebrovascular accident, pneumonia, pulmonary embolism, urinary tract infections, wound complications, acute congestive heart failure exacerbation and nonhome discharge. A P value of <0.05 was considered significant for all the analyses. RESULTS: The study cohort comprised 359 patients. The GBPs group comprised 125 patients with a mean (standard deviation) age of 61.6 (±10.2) years and the no-GBPs group consisted of 234 patients with a mean (standard deviation) age of 64.6 (±12.2) years. Patients in GBPs group were likely to be younger (P = 0.014), undergo LEB for chronic limb-threatening ischemia (P = 0.039), and have insulin-dependent diabetes mellitus (P < 0.001) than the no-GBPs group. In terms of outcomes, the patients in the GBPs group were more likely to have longer postoperative length of stay (9.3 ± 11.1 vs. 6.4 ± 5.0 days no GBPs, P = 0.008). In multivariable analysis, the patients in the GBPs group had 92% (adjusted odds ratio 1.92 [1.16, 3.18], P = 0.01) increase in the odds of having a length of stay above 6-day calculated median in comparison to the no-GBPs group. CONCLUSION: This retrospective analysis of patients undergoing LEB at a tertiary care hospital shows a significant association between preoperative GBPs use and the longer postoperative length of stay. This study bridges a gap in the current body of knowledge regarding the association of GBP use with the postoperative outcomes in patients undergoing LEB for severe peripheral artery disease.
引用
- Samaan F, Lavanga E, Dogbe L, et al. Preoperative History of Gabapentinoids Use is Associated with Longer Length of Hospital Stay in Patients Undergoing Lower Extremity Bypass Surgery for Severe Peripheral Artery Disease. Ann Vasc Surg. 2025. PMID: 40054604. doi:10.1016/j.avsg.2025.02.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。